Etoposide induced cytotoxicity mediated by ROS and ERK in human kidney proximal tubule cells.
Etoposide (ETO) is a commonly used chemotherapeutic drug that inhibits topoisomerase II activity, thereby leading to genotoxicity and cytotoxicity. However, ETO has limited application due to its side effects on normal organs, especially the kidney. Here, we report the mechanism of ETO-induced cytotoxicity progression in human kidney proximal tubule (HK-2) cells. Our results show that ETO perpetuates DNA damage, activates mitogen-activated protein kinase (MAPK), and triggers morphological changes, such as cell and nuclear swelling. When NAC, a well-known reactive oxygen species (ROS) scavenger, is co-treated with ETO, it inhibits an ETO-induced increase in mitochondrial mass, mitochondrial DNA (ND1 and ND4) copy number, intracellular ATP level, and mitochondrial biogenesis activators (TFAM, PGC-1α and PGC-1β). Moreover, co-treatment with ETO and NAC inhibits ETO-induced necrosis and cell swelling, but not apoptosis. Studies using MAPK inhibitors reveal that inhibition of extracellular signal regulated kinase (ERK) protects ETO-induced cytotoxicity by inhibiting DNA damage and caspase 3/7 activity. Eventually, ERK inhibitor treated cells are protected from ETO-induced nuclear envelope (NE) rupture and DNA leakage through inhibition of caspase activity. Taken together, these data suggest that ETO mediates cytotoxicity in HK-2 cells through ROS and ERK pathways, which highlight the preventive avenues in ETO-induced cytotoxicity in kidney.
Department of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Hyeon-Jun
HJ
Shin
Department of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Hyuk-Kwon
HK
Kwon
Department of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.|Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, USA.
Jae-Hyeok
JH
Lee
Department of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Muhammad Ayaz
MA
Anwar
Department of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Sangdun
S
Choi
Science. 2002 Dec 6;298(5600):1911-2
12471242
J Am Soc Nephrol. 2011 Mar;22(3):431-6
21355058
Bone Marrow Transplant. 1997 Nov;20(10):813-9
9404920
Nat Rev Mol Cell Biol. 2010 May;11(5):317-28
20414256
J Toxicol. 2012;2012:645460
22919381
Sci Rep. 2015 Oct 22;5:15623
26490051
Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14
20823910
Nat Rev Cancer. 2014 Nov;14(11):709-21
25342630
Kidney Int. 2008 May;73(9):994-1007
18272962
Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1775-89
16987031
Oncogene. 2007 May 14;26(22):3203-13
17496916
Cell Signal. 2012 May;24(5):981-90
22286106
Nat Rev Drug Discov. 2013 Dec;12(12):931-47
24287781
J Cell Sci. 1999 Jun;112 ( Pt 11):1743-53
10318766
EMBO J. 1998 May 15;17(10):2721-7
9582265
Gene Expr. 1999;7(4-6):321-35
10440233
Ultramicroscopy. 2008 Sep;108(10):1163-7
18572322
J Signal Transduct. 2012;2012:463617
22523682
Acta Biomater. 2015 Sep;24:279-85
26102337
Nat Rev Mol Cell Biol. 2010 Jul;11(7):490-501
20571586
PLoS One. 2015 Aug 06;10(8):e0135083
26247588
Oncogene. 2004 Apr 12;23(16):2838-49
15077147
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000539
20300205
Trends Endocrinol Metab. 2009 Sep;20(7):332-40
19733481
Oncogene. 2007 May 14;26(22):3279-90
17496922
J Biol Chem. 2003 May 23;278(21):19245-56
12637505
Genes Dev. 2008 Apr 1;22(7):832-53
18381888
Cell Death Differ. 2001 Jun;8(6):588-94
11536009
Nat Rev Mol Cell Biol. 2008 Mar;9(3):231-41
18073771
J Biol Chem. 2006 Jan 13;281(2):1296-304
16286466
Nat Rev Mol Cell Biol. 2003 Oct;4(10):757-66
14570049
J Biol Chem. 2000 Mar 31;275(13):9390-5
10734083
J Signal Transduct. 2011;2011:792639
21637379
PLoS One. 2012;7(9):e44990
23028726
Carcinogenesis. 2002 Nov;23 (11):1831-8
12419831
Sci Rep. 2015 Nov 02;5:15798
26522181
Eur J Cancer. 1998 Sep;34(10):1514-21
9893622
Diabetes. 2005 May;54(5):1392-9
15855325
Biochem Biophys Res Commun. 2005 Oct 14;336(1):357-63
16139248
Int J Nephrol. 2012;2012:465897
22577546
Nat Rev Cancer. 2013 May;13(5):299-314
23612459
J Pharm Sci. 2007 Sep;96(9):2181-96
17593552
Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16507-12
15545607
Cancer. 1991 Jan 1;67(1 Suppl):319-29
1984835
Antioxid Redox Signal. 2007 Jan;9(1):49-89
17115887
J Biol Chem. 2000 Dec 15;275(50):39435-43
10993883
Toxicol Pathol. 2007 Jun;35(4):495-516
17562483
PLoS One. 2012;7(10):e46536
23094027
Nat Rev Endocrinol. 2014 Nov;10(11):650-8
25200564
Toxicol Sci. 2015 Nov;148(1):204-19
26259609
Nat Rev Mol Cell Biol. 2012 Dec;13(12):780-8
23175281
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
19478820
J Cell Biol. 1990 Apr;110(4):883-94
2324201
Annu Rev Physiol. 2009;71:177-203
19575678
Mol Cell Biochem. 2015 Nov;409(1-2):33-43
26169986
PLoS One. 2008 Apr 23;3(4):e2009
18431490
Dent Mater. 2010 Jan;26(1):51-8
19767088
J Am Soc Nephrol. 2013 Oct;24(10):1512-8
23970124
Cell Death Differ. 2001 May;8(5):495-505
11423910